Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis.
about
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR ImagingDiagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis(68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade gliomaAdvances in neuro-oncology imaging.An Update on the Approach to the Imaging of Brain Tumors.18F-fluorothymidine PET imaging in gliomas: an update.Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review.SapC-DOPS nanovesicles: a novel targeted agent for the imaging and treatment of glioblastomaFollow-Up Imaging: Molecular Imaging is Likely Best as a Single Modality, but Multimodality Imaging is the FutureResponse Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Neurologic Applications of PET/MR Imaging.Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial.Management of supratentorial recurrent low-grade glioma: A multidisciplinary experience in 35 adult patients.Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis.Diagnostic accuracy of 11C-methionine PET in detecting neuropathologically confirmed recurrent brain tumor after radiation therapy.Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study.Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors.Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.Positron emission tomography (PET) for prediction of glioma histology: protocol for an individual-level data meta-analysis of test performance.Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma
P2860
Q26796223-C7F3FC10-7CB8-4431-AC66-BF5AAE4E6583Q28088506-2907CE70-9FEA-4FA7-9E6F-58B5A97CAE57Q34473605-EA57121D-47EA-4E66-9307-B4DF1D6A6371Q36107374-6ACAD0B9-60F4-452A-B18F-A7D915615C1CQ36118131-66182F5B-69AC-4959-85A6-3EF0FC3E1BE3Q36339461-2FAB8948-4CE2-46FE-9C1D-8F82BB952452Q36374577-886B9D2B-C045-470B-BB22-1763526FD2C5Q36404866-51744A3B-D35D-4BD2-99AA-C2C9107A3C8FQ38197532-1C561E91-4D8D-4BB3-BD80-DE196EBD455DQ38414026-CDBFA4F6-0EC3-4DA5-80A5-7A44C0178A13Q38474606-BA78E690-878D-47D6-880A-72C8283C88E7Q38815396-47CA2C10-9C6A-41D3-AC47-EECFAF277686Q38846608-E9617E52-4DD1-49FA-A191-53986FF701D9Q39051286-748E9FC2-E890-41C3-B7FC-B312C399FF12Q41026634-B5789FEA-8EA3-4A80-964C-D7B90E784FCAQ41597504-5ECC7DF1-D562-4751-91E7-780F110CBAB2Q41994160-D79E0E89-0045-4998-85DE-33DA79A0E6E2Q45179517-2C0507C5-2B51-463E-876C-0888076CA474Q47307220-435054D2-12A5-440B-B951-A33455CE7391Q47367363-40A6273A-14D4-4DE7-A1C6-710300D6ADCCQ47894451-50DC9541-AE03-4564-8649-478BFBBB2328Q48246048-B1CFB008-7F45-471E-88EF-F09369CC0B1DQ48457964-31C11983-1245-47A5-AA7C-608729F4C5B7Q48681387-348A6929-9157-4813-BCC0-6D5BE1571BAFQ48787135-C344BA01-9CE0-47ED-BEA9-0937436E623CQ49829513-E0475BC5-9E64-4591-8E7A-1AA38C27E84AQ49893451-B1CC04F7-152D-4217-A52B-D1C52A193F7DQ50907799-AD89CBFD-7F0C-455C-8DCB-FAC40AB0C56AQ52629217-12B4EB02-3968-429A-B9BB-D08EA0F858A9Q54135407-686FBC6C-79F5-4133-A384-3B431BD36793Q58730832-07EEB7F3-2A4D-4CD4-BDF4-579195B7E07B
P2860
Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis.
@en
type
label
Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis.
@en
prefLabel
Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis.
@en
P2093
P356
P1476
Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis.
@en
P2093
I J Dahabreh
T Terasawa
P304
944-50, S1-11
P356
10.3174/AJNR.A3324
P577
2012-11-01T00:00:00Z